- NCIt
- C45485
Loading cancer entity…
Loading cancer entity…
Clinical trials
4 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00975819 | Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies | completed | Phase 2 | 61 | Denise Martin AdamsOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT05050149 | Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations | completed | Phase 2 | 12 | Palvella Therapeutics, Inc.INDUSTRY | 1 | Jan 17, 2025 | clinicaltrials |
Data updated 22 days agoSource updated Jan 6, 2026source: clinicaltrials